| Business Summary |
| A biotechnology company which focuses on drug discovery & early-stage development of pharmaceuticals that address critical unmet medical needs or that are more effective or safer than existing therapies, more convenient to administer & are cost effec |
| General Information |
10275 Science Center Drive
San Diego, CA 92121-1117
|
| www.ligand.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 96 |
| CEO: John L. Higgins |
| Short Interest |
| Current Month (Mil) |
3.99 |
| Previous Month (Mil) |
3.81 |
| Short Interest Ratio (Days) |
9.90 |
| Management Effectiveness |
| Return on Equity |
N.A. |
| Return on Assets |
-63.70 |
| Return on Investments |
-208.00 |
| Profitability |
| Gross Margin |
70.20 |
| EBIT Margin |
N.A. |
| Profit Margin |
0.00 |